DoW Peer Reviewed Medical, Research Advancement Award

DOD-AMRAA Posted HT942526PRMRPRAA

Description

Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Research Advancement Award supports fundamental research studies that will make an important contribution towards research, patient care, and/or quality of life for a disease or condition related to one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP portfolio-specific strategic goals. Distinctive Features: Applications must include preliminary data. The Research Advancement Award supports use-inspired basic research to further or validate preliminary findings for short- and long-term impact. Proposed research projects may range from hypothesis testing to expansion of mature data. Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $19.6M to fund approximately 14 Research Advancement Award applications with total cost caps of $1.4M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Funding Details
Award Floor
Not specified
Award Ceiling
Not specified
Total Estimated Funding
$19,600,000.00
Expected Awards
14
Key Dates
Posted
May 8, 2026
Closes
July 30, 2026
Archive Date
August 29, 2026
Agency Information
Agency Name
Defense Health Agency Contracting Activity - DHACA
Agency Code
DOD-AMRAA
Funding Instrument
Other